$1.30
arrow_drop_down1.51%Key Stats | |
---|---|
Open | $1.35 |
Prev. Close | $1.32 |
EPS | -1.42 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $73.35M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.33 | 1.35 |
52 Week Range | 1.22 | 6.30 |
Ratios | |
---|---|
EPS | -1.42 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers